Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 986406263
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2013.03.14, US 201361784964 P
CARERI M ET AL: "Use of specific peptide biomarkers for quantitative confirmation of hidden allergenic peanut proteins Ara h 2 and Ara h 3/4 for food control by liquid chromatography-tandem mass spectrometry", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, SPRINGER, BERLIN, DE, vol. 389, no. 6, 27 September 2007 (2007-09-27), pages 1901-1907, XP019559855, ISSN: 1618-2650, DOI: 10.1007/S00216-007-1595-2 (B1)
YONGHUA ZHUANG & STEPHEN C DRESKIN: "Redefining the major peanut allergens", IMMUNOLOGIC RESEARCH, HUMANA PRESS INC, NEW YORK, vol. 55, no. 1 - 3, 5 September 2012 (2012-09-05), pages 125-134, XP035163210, ISSN: 1559-0755, DOI: 10.1007/S12026-012-8355-X & M. KULIS ET AL: "The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice", CLINICAL & EXPERIMENTAL ALLERGY : JOURNAL OF THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY, vol. 42, no. 2, 30 January 2012 (2012-01-30), pages 326-336, XP055296982, UK ISSN: 0954-7894, DOI: 10.1111/j.1365-2222.2011.03934.x (B1)
H. BERNARD ET AL: "Identification of a New Natural Ara h 6 Isoform and of Its Proteolytic Product as Major Allergens in Peanut", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 55, no. 23, 1 November 2007 (2007-11-01), pages 9663-9669, XP055286329, US ISSN: 0021-8561, DOI: 10.1021/jf071424g (B1)
H. Singh ET AL: "Meeting Abstract - Developing RP-HPLC method for detection of peanut allergens", AACC International Annual Meeting, 16 October 2011 (2011-10-16), XP055286328, Retrieved from the Internet: URL:http://www.aaccnet.org/meetings/Docume nts/2011Abstracts/p11ma199.htm [retrieved on 2016-07-06] (B1)
HUGH A SAMPSON ET AL: "A phase II, randomized, double blind, parallel group, placebo controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 127, no. 5, 11 March 2011 (2011-03-11), pages 1309-1310.e1, XP028198125, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2011.01.051 [retrieved on 2011-02-02] (B1)
KALYANA PINGALI ET AL: "Mixing order of glidant and lubricant - Influence on powder and tablet properties", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 409, no. 1-2, 16 May 2011 (2011-05-16), pages 269-277, XP55420547, NL ISSN: 0378-5173, DOI: 10.1016/j.ijpharm.2011.02.032 (B1)
KATRIN LEHMANN ET AL: "Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions", BIOCHEMICAL JOURNAL, vol. 395, no. 3, 1 May 2006 (2006-05-01), pages 463-72, XP055151232, ISSN: 0264-6021, DOI: 10.1042/BJ20051728 (B1)
KOPPELMAN STEF J ET AL: "Heat-induced conformational changes of Ara h 1, a major peanut allergen, do not affect its allergenic properties", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 274, no. 8, 19 February 1999 (1999-02-19), pages 4770-4777, XP002306987, ISSN: 0021-9258, DOI: 10.1074/JBC.274.8.4770 (B1)
O'CONNELL R.: "Uses of Sieves in the II Pharmaceutical Industry and the Increased Demand for Containment", INTERNATIONAL PHARMACEUTICAL INDUSTRY, vol. 4, no. 4, 10 December 2012 (2012-12-10), pages 88-90, XP055420558, (B1)
PALISADE: "AR101 Oral Immunotherapy for Peanut Allergy", THE NEW ENGLAND JOURNAL OF MEDICINE, - NEJM -, vol. 379, no. 21, 22 November 2018 (2018-11-22), pages 1991-2001, XP055675924, US ISSN: 0028-4793, DOI: 10.1056/NEJMoa1812856 (B1)
PODCZECK F ET AL: "The filling of granules into hard gelatine capsules", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 188, no. 1, 15 October 1999 (1999-10-15), pages 59-69, XP009508742, ISSN: 0378-5173, DOI: 10.1016/S0378-5173(99)00208-2 [retrieved on 1990-10-19] (B1)
STEF J. KOPPELMAN ET AL: "Digestion of peanut allergens Ara h 1, Ara h 2, Ara h 3, and Ara h 6: A comparative in vitro study and partial characterization of digestion-resistant peptides", MOLECULAR NUTRITION & FOOD RESEARCH, vol. 54, no. 12, 1 December 2010 (2010-12-01), pages 1711-1721, XP055296935, DE ISSN: 1613-4125, DOI: 10.1002/mnfr.201000011 (B1)
TAN S B & NEWTON J M: "Powder flowability as an indication of capsule filling performance", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 61, no. 1-2, 11 June 1990 (1990-06-11), pages 145-155, XP025557756, ISSN: 0378-5173, DOI: 10.1016/0378-5173(90)90053-7 [retrieved on 1990-06-11] (B1)
WILLIAM CURATOLO ET AL: "Effects of Food on a Gastrically Degraded Drug: Azithromycin Fast-Dissolving Gelatin Capsules and HPMC Capsules", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, vol. 28, no. 7, 18 February 2011 (2011-02-18), pages 1531-1539, XP019912546, ISSN: 1573-904X, DOI: 10.1007/S11095-011-0386-9 (B1)
WO-A1-2012/123759 (B1)
FUNG IRENE ET AL: "Relating microarray component testing and reported food allergy and food-triggered atopic dermatitis: a real-world analysis", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 110, no. 3, 8 January 2013 (2013-01-08), page 173, XP028988049, ISSN: 1081-1206, DOI: 10.1016/J.ANAI.2012.12.006 (B1)
-
Status: Anmerket i registerAvtalen inngått:Melding innkommet Patentstyret:Avtalen opphørt:Lisenstype: EksklusivInfo: Gjelder hele rettigheten. Melding om lisens innkom Patentstyret 2024.01.18Lisensgiver:Société des Produits Nestlé S.A.Avenue Nestlé 55 1800 VEVEY CHLisenstaker:STALLERGENES GREER INTERNATIONAL AGZugerstrasse 76B 6340 BAAR CH
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3482771)
|
Innkommende, AR542370565
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 12. avg. år (EP) | 2025.03.12 | 5010 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2024.02.22 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
32303432 expand_more expand_less | 2023.03.30 | 5500 | PLOUGMANN VINGTOFT NUF | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 10. avg. år (EP) | 2023.03.27 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |